These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37124826)

  • 1. Effectiveness of non-pharmaceutical interventions in nine fields of activity to decrease SARS-CoV-2 transmission (Spain, September 2020-May 2021).
    Barbeito I; Precioso D; Sierra MJ; Vegas-Azcárate S; Fernández Balbuena S; Vitoriano B; Goméz-Ullate D; Cao R; Monge S;
    Front Public Health; 2023; 11():1061331. PubMed ID: 37124826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the effect of non-pharmaceutical interventions on COVID-19 transmission in Spain, 30 August 2020 to 31 January 2021.
    García-García D; Herranz-Hernández R; Rojas-Benedicto A; León-Gómez I; Larrauri A; Peñuelas M; Guerrero-Vadillo M; Ramis R; Gómez-Barroso D
    Euro Surveill; 2022 May; 27(19):. PubMed ID: 35551707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the relationship between interventions, contact patterns, and SARS-CoV-2 transmissibility.
    Trentini F; Manna A; Balbo N; Marziano V; Guzzetta G; O'Dell S; Kummer AG; Litvinova M; Merler S; Ajelli M; Poletti P; Melegaro A
    Epidemics; 2022 Sep; 40():100601. PubMed ID: 35772295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stringency of containment and closures on the growth of SARS-CoV-2 in Canada prior to accelerated vaccine roll-out.
    Vickers DM; Baral S; Mishra S; Kwong JC; Sundaram M; Katz A; Calzavara A; Maheu-Giroux M; Buckeridge DL; Williamson T
    Int J Infect Dis; 2022 May; 118():73-82. PubMed ID: 35202783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of non-pharmaceutical interventions to reduce SARS-CoV-2 transmission in Canada and their association with COVID-19 hospitalization rates.
    Rees EE; Avery BP; Carabin H; Carson CA; Champredon D; de Montigny S; Dougherty B; Nasri BR; Ogden NH
    Can Commun Dis Rep; 2022 Oct; 48(10):438-448. PubMed ID: 38162959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the controlled reopening of nightlife during the COVID-19 pandemic: a matched cohort study in Sitges, Spain, in May 2021 (Reobrim Sitges).
    Cunillera Puértolas O; Contreras-Martos S; Marzo-Castillejo M; López Gallegos D; Acedo Anta M; Almeda Ortega J; Colom J; Basora J; Salvador-Gonzalez B
    BMJ Open; 2022 Jun; 12(6):e058595. PubMed ID: 35649590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 spread and area economic disadvantage in the italian three-tier restrictions: a multilevel approach.
    Dei Bardi L; Acampora A; Cacciani L; Di Martino M; Agabiti N; Davoli M; Cesaroni G
    BMC Public Health; 2023 Feb; 23(1):329. PubMed ID: 36788600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 prevalence and transmission in swimming activities: Results from a retrospective cohort study.
    Termansen MB; Christiansen AV; Frische S
    Scand J Med Sci Sports; 2022 Jan; 32(1):242-254. PubMed ID: 34606662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associative evidence for the potential of humidification as a non-pharmaceutical intervention for influenza and SARS-CoV-2 transmission.
    Keetels GH; Godderis L; van de Wiel BJH
    J Expo Sci Environ Epidemiol; 2022 Sep; 32(5):720-726. PubMed ID: 36104526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
    Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterising social contacts under COVID-19 control measures in Africa.
    Dobreva Z; Gimma A; Rohan H; Djoudalbaye B; Tshangela A; Jarvis CI; van Zandvoort K; Quaife M
    BMC Med; 2022 Oct; 20(1):344. PubMed ID: 36221094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
    Marks M; Millat-Martinez P; Ouchi D; Roberts CH; Alemany A; Corbacho-Monné M; Ubals M; Tobias A; Tebé C; Ballana E; Bassat Q; Baro B; Vall-Mayans M; G-Beiras C; Prat N; Ara J; Clotet B; Mitjà O
    Lancet Infect Dis; 2021 May; 21(5):629-636. PubMed ID: 33545090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.
    Goupil de Bouillé J; Luong Nguyen LB; Crépey P; Garlantezec R; Doré V; Dumas A; Ben Mechlia M; Tattevin P; Gaudart J; Spire B; Lert F; Yazdanpanah Y; Delaugerre C; Noret M; Zeggagh J
    Front Public Health; 2022; 10():981213. PubMed ID: 36438274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis.
    Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of social distancing on early SARS-CoV-2 transmission in the United States.
    Sanchez JN; Reyes GA; Martínez-López B; Johnson CK
    Zoonoses Public Health; 2022 Sep; 69(6):746-756. PubMed ID: 35048530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the perceived effect of non-pharmaceutical interventions on SARS-Cov-2 transmission risk: an experimental study in Europe.
    Veltri GA; Steinert JI; Sternberg H; Galizzi MM; Fasolo B; Kourtidis P; Büthe T; Gaskell G
    Sci Rep; 2024 Feb; 14(1):4857. PubMed ID: 38418636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stringency of the containment measures in response to COVID-19 inversely correlates with the overall disease occurrence over the epidemic wave.
    Mezencev R; Klement C
    Bratisl Lek Listy; 2022; 123(9):601-617. PubMed ID: 36039877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.